The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-(3-Methoxyphenyl)-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylamine ID: ALA494724
PubChem CID: 25131229
Max Phase: Preclinical
Molecular Formula: C16H21N5O
Molecular Weight: 299.38
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1cccc(-c2cc(N3CCN(C)CC3)nc(N)n2)c1
Standard InChI: InChI=1S/C16H21N5O/c1-20-6-8-21(9-7-20)15-11-14(18-16(17)19-15)12-4-3-5-13(10-12)22-2/h3-5,10-11H,6-9H2,1-2H3,(H2,17,18,19)
Standard InChI Key: JNBIWTQSSTVWAN-UHFFFAOYSA-N
Molfile:
RDKit 2D
22 24 0 0 0 0 0 0 0 0999 V2000
14.0753 -7.8504 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.0741 -8.6774 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7886 -9.0901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5047 -8.6769 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.5018 -7.8468 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.7868 -7.4379 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.2171 -9.0873 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.2164 -9.9129 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9271 -10.3239 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.6431 -9.9140 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
17.6438 -9.0885 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.9285 -8.6728 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
18.3562 -10.3279 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.7843 -6.6133 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
13.3616 -9.0894 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6474 -8.6748 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9335 -9.0859 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9324 -9.9114 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6512 -10.3241 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3623 -9.9106 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.6535 -11.1487 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
13.3688 -11.5590 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9 10 1 0
10 11 1 0
11 12 1 0
4 7 1 0
6 1 1 0
10 13 1 0
7 8 1 0
6 14 1 0
1 2 2 0
3 4 2 0
15 16 2 0
16 17 1 0
4 5 1 0
17 18 2 0
2 3 1 0
18 19 1 0
5 6 2 0
19 20 2 0
20 15 1 0
2 15 1 0
7 12 1 0
19 21 1 0
8 9 1 0
21 22 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 299.38Molecular Weight (Monoisotopic): 299.1746AlogP: 1.49#Rotatable Bonds: 3Polar Surface Area: 67.51Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.61CX LogP: 2.32CX LogD: 1.88Aromatic Rings: 2Heavy Atoms: 22QED Weighted: 0.93Np Likeness Score: -1.43
References 1. Altenbach RJ, Adair RM, Bettencourt BM, Black LA, Fix-Stenzel SR, Gopalakrishnan SM, Hsieh GC, Liu H, Marsh KC, McPherson MJ, Milicic I, Miller TR, Vortherms TA, Warrior U, Wetter JM, Wishart N, Witte DG, Honore P, Esbenshade TA, Hancock AA, Brioni JD, Cowart MD.. (2008) Structure-activity studies on a series of a 2-aminopyrimidine-containing histamine H4 receptor ligands., 51 (20): [PMID:18811133 ] [10.1021/jm8005959 ]